Josef Coresh
Tracked across 2 events · 52 articles · First seen Aug 05, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Senior investigator and spokesperson, raising his profile in the field of aging and dementia research.
Aug 05, 2026 · 24 articles
Tech
The U.S. United States — Food and Drug Administration cleared the PrecivityAD2 blood test, developed by C2N Diagnostics, a startup founded by researchers at Washington University in St. Louis, to help evaluate Alzheimer's disease in…
Impact: Senior author of the NYU Langone Health study showing that avoiding high blood pressure, diabetes and smoking in middle age extends dementia-free life.
Aug 21, 2026 · 28 articles
35
Josef Coresh advised aggressive preventionFDA Clears C2N Alzheimer Blood Test
ERGEN INTELLIGENCE
Track Josef Coresh live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard